Andelyn Biosciences Chosen by Hubble Therapeutics to Manufacture Gene Therapy for Rare Childhood Blindness Disorder

Generics |  News | 0 Comment | 11 Oct, 2024

 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...Read more

Hyphens Pharma launches treatment for Atopic dermatitis (Eczema) expanding it’s Ceradan® series

Generics |  News | 0 Comment | 19 Sep, 2024

Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, ...Read more

Addressing Supply Chain Vulnerabilities in the Global Pharmaceutical Industry

Generics |  News | 0 Comment | 22 Aug, 2024

Industries with international operations face increasing vulnerability to supply chain disruptions. This risk is particu...Read more

Chinese generic drug for breast, pancreatic, and lung cancer approved in EU market

Generics |  News | 0 Comment | 31 Jul, 2024

Apexelsin, a generic drug from China been approved by the European Commission. Apexelsin is a generic dru...Read more

China Life Science Conference and China Life Science Expo (CILSE) Set to Drive Innovation and Collaboration in Guangzhou

Generics |  News | 0 Comment | 07 Mar, 2024

The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...Read more

Asia Pacific Forum on Precision Cancer Treatment at Taiwan Healthcare+ Expo 2023, Wraps Up with Robust Discussions and Deep Insights

Generics |  News | 0 Comment | 01 Dec, 2023

The third edition of the "Asia Pacific Forum on Precision Cancer Treatment" concluded today with a dynamic exchange of i...Read more

“Generic manufacturers will likely face increasing challenges such as pricing pressures driven by 'un-branding' efforts”

Generics |  Opinion | 0 Comment | 04 Jul, 2023

How did the company perform during FY 2022-23?  The company is currently in a recovery phase following the impact ...Read more

Generic manufacturers from India & Indonesia bring affordable drug for cancer treatment

Generics |  News | 1 Comment | 23 Jun, 2023

The Medicines Patent Pool (MPP), a United Nations-backed public health organisation, has signed sublicence agreemen...Read more

Australia-based Mayne Pharma sells US generic prescription product portfolio for $90 M

Generics |  News | 0 Comment | 28 Feb, 2023

Dr. Reddy's Laboratories SA, a wholly-owned subsidiary of Indian pharmaceutical company Dr. Reddy’s Laboratories, ...Read more

Indian pharma firm Venus Remedies gets marketing approval for cancer drugs in Uzbekistan, Palestine

Generics |  News | 0 Comment | 23 Feb, 2023

Indian pharmaceutical company Venus Remedies has received marketing authorisation for its generic cancer drugs from Uzbe...Read more

ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist

Generics |  News | 0 Comment | 28 Sep, 2022

Trans-Atlantic private equity healthcare specialist ArchiMed has invested in Bielefeld, Germany-based PlasmidFactory. Fo...Read more

Portfolio Management and Pipeline Optimization for Generics (15th Edition) conference to unravel global generic pharma market opportunities

Generics |  News | 0 Comment | 08 Aug, 2022

Pharmaceutical companies need to ensure they have a competitive edge in the market while adapting to evolving industry b...Read more

35 manufacturers sign agreements to produce generic versions of Pfizer's oral COVID-19 drug

Generics |  News | 0 Comment | 18 Mar, 2022

The Medicines Patent Pool (MPP) has signed agreements with 35 companies to manufacture the generic version of Pfizer's o...Read more

Taiwan approves new first-line treatment for advanced renal cell carcinoma

Generics |  News | 0 Comment | 31 Jan, 2022

Eisai Co. has announced that LENVIMA (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase inh...Read more

Eisai to market Gilead’s rheumatoid arthritis drug in Asia

Generics |  News | 0 Comment | 23 Dec, 2021

Japanese firm Eisai has entered into an agreement with Gilead Sciences, Inc. for the commercialisation and distribution ...Read more

Biocon partners with Tabuk Pharma to commercialise speciality generic medicines in Middle East

Generics |  News | 0 Comment | 08 Dec, 2021

Indian firm Biocon has announced a partnership with Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary...Read more

C2 PHARMA Completes Multiple Local Regulatory Filings and Expands Portfolio

Generics |  News | 0 Comment | 10 Nov, 2021

Multiple regulatory filings have been submitted to expand distribution channels globally across China, Taiwan, South Kor...Read more

Patient access to gene therapies for cancer set to increase in next decade: GlobalData

Generics |  News | 0 Comment | 25 Jun, 2021

Gene therapies will provide a valid treatment option for patients that have developed resistance to chemotherapies acros...Read more